In 2023, the pharmaceutical company reported positive feedback after Phase 2 testing of the drug. It found that after 24 weeks, participants with obesity or those overweight (without diabetes ...

In the race to find Ozempic 2.0, a few stand-outs are emerging. While GLP-1 drugs have paved the way for a new era of healthcare, they have some drawbacks. They need to be injected (a draw-back ...

There have been numerous reports on social media platforms like TikTok and Instagram where women have shared experiences of ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a ...

A popular diabetes drug just got a major new approval—and it could be a game-changer for millions of Americans at risk for ...

Approval was based on results from the Phase IIIb FLOW trial, which demonstrated a 24% relative risk reduction in kidney ...

Ozempic, or semaglutide, can now be used to reduce the risk of worsening kidney disease or kidney failure in adults with type ...

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

The FDA has approved a new indication for semaglutide to lower the risk for worsening kidney disease, kidney failure and ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.